Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus TP chemoradiotherapy for esophageal cancer
ChiCTR1900021279Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of endostar in esophageal cancer (2 arms), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Objective response rate and Progression-free survival. Started Feb 2019; status: recruiting.
02
Drugs
endostar
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR1900021279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021279.